Benicar HCT (olmesartan medoxomil-hydrochlorothiazide)
Title: Benicar HCT (olmesartan medoxomil-hydrochlorothiazide)Category: MedicationsCreated: 11/8/2021 12:00:00 AMLast Editorial Review: 11/8/2021 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - November 8, 2021 Category: Cardiology Source Type: news
Benicar (olmesartan medoxomil)
Title: Benicar (olmesartan medoxomil)Category: MedicationsCreated: 11/8/2021 12:00:00 AMLast Editorial Review: 11/8/2021 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - November 8, 2021 Category: Cardiology Source Type: news
What Are the Bad Side Effects of Benicar
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 1, 2021 Category: General Medicine Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: FDA aprueba cambios en la etiqueta para problemas intestinales (enteropat ía similar a esprue) asociada con el medicamento olmesartán medoxomil para la presión alta
El 3 de julio, 2013, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) advirtió que el medicamento para la presión alta olmesartán medoxomil (comercializado como Benicar, Benicar HCT, Azor, Tribenzor y genéricos) ha sido asociado con problemas intestinales conocidos como enteropatía similar a esprue, y la agencia ha aprobado cambios en las etiquetas de estos medicamentos que mencionan esta inquietud. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 19, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide)
Title: Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide)Category: MedicationsCreated: 10/21/2020 12:00:00 AMLast Editorial Review: 10/21/2020 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - October 21, 2020 Category: Cardiology Source Type: news
Azor (amlodipine and olmesartan medoxomil)
Title: Azor (amlodipine and olmesartan medoxomil)Category: MedicationsCreated: 10/13/2020 12:00:00 AMLast Editorial Review: 10/13/2020 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - October 13, 2020 Category: Cardiology Source Type: news
Olmesartan Medoxomil Tablets (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 5, 2019 Category: Drugs & Pharmacology Source Type: news
Olmesartan Medoxomil Tablets (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 12, 2019 Category: Drugs & Pharmacology Source Type: news
Amlodipine Besylate and Olmesartan Medoxomil Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - March 11, 2019 Category: Drugs & Pharmacology Source Type: news
Olmesartan Medoxomil and Hydrochlorothiazide Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 21, 2018 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: Safety Review Update of Benicar (olmesartan) and cardiovascular events
This safety review update is in follow-up to the FDA Drug Safety Communication:Ongoing Safety Review of Benicar (olmesartan) and cardiovascular events on 6/11/2010. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 15, 2017 Category: Drugs & Pharmacology Source Type: news
Lupin launches generic hypertension drug in US market
The Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment of hypertension. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 4, 2017 Category: Pharmaceuticals Source Type: news
Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar
NEW YORK (Reuters) - Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of failing to warn that its blood pressure medication Benicar can cause gastrointestinal illness. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
Jubilant Life gets USFDA nod for hypertension drug
In a BSE filing, the company said it has received abbreviated new drug application (ANDA) final approval for olmesartan medoxomil tablets - 5 mg, 20 mg, and 40 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 25, 2017 Category: Pharmaceuticals Source Type: news
Alembic Pharma gets USFDA nod for anti-hypertension drugs
The approved products are therapeutically equivalent to the reference listed drug products Benicar and Benicar HCT of Daiichi Sankyo, which is used for the treatment of hypertension, it said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 25, 2017 Category: Pharmaceuticals Source Type: news
